Papers/PMID:32722790
Effects of Dose and Duration of Zinc Interventions on Risk Factors for Type 2 Diabetes and Cardiovascular Disease: A Systematic Review and Meta-Analysis.
Advances in nutrition (Bethesda, Md.)2021The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
Zn(2+) — no detected effect on HDL cholesterol
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“There was no effect of zinc supplementation on HDL cholesterol for either low- or high-dose supplementation.”
Quoted verbatim from Effects of Dose and Duration of Zinc Interventions on Risk Factors for Type 2 Diabetes and Cardiovascular Disease: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Dose
- up to 75 mg/d elemental zinc; low <25 mg/d and high >=25 mg/d strata
- Population
- Participants (healthy, obese, type 2 diabetes, prediabetes, haemodialysis and other groups, children to older adults) in randomised trials of zinc supplements up to 75 mg/d versus placebo or control, pooled within low-dose and high-dose strata
Effects of Dose and Duration of Zinc Interventions on Risk Factors for Type 2 Diabetes and Cardiovascular Disease: A Systematic Review and Meta-Analysis.2021PMID:32722790Industry fundedPermalink